Clinical Trials Browser

Phase 2 × Pemetrexed × Gynecologic × Clear all

NCT06630325 2026-04-28

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Terminated

6 enrolled 3 charts

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT03875144 2026-02-09

MESOTIP

Phase 2 Suspended

Peritoneal Neoplasms

NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms, Recurrence

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Phase 2 Completed

139 enrolled 14 charts

EndocrineGynecologicNETThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT01001910 2024-02-28

Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

22 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00230542 2018-08-13

Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00096187 2018-04-12

Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy

Phase 2 Terminated

Gestational Trophoblastic Disease

NCT00691301 2018-01-09

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 2 Completed

55 enrolled 10 charts

Uterine Cervical Neoplasms

NCT00868192 2014-10-20

Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

Phase 2 Completed

38 enrolled 17 charts

Ovarian Neoplasms

NCT00087087 2014-02-14

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00087100 2014-02-14

Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Completed

Endometrial Neoplasms

NCT00087113 2014-02-14

Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

Phase 2 Completed

Uterine Cervical Neoplasms

NCT00461786 2009-12-04

A Study of Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

Phase 2 Completed

51 enrolled 15 charts

Ovarian Neoplasms

NCT00190983 2009-11-20

A Trial for Patients With Advanced/Recurrent Cervical Cancer

Phase 2 Completed

29 enrolled 14 charts

Uterine Cervical Dysplasia, Genital Neoplasms, Female, Uterine Neoplasms

NCT00377520 2009-11-20

A Trial for Patients With Advanced/Recurrent Endometrial Cancer

Phase 2 Completed

27 enrolled 10 charts

Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT00190918 2007-08-09

A Trial for Patients With Gestational Trophoblastic Disease

Phase 2 Completed

Choriocarcinoma, Hydatidiform Mole, Trophoblastic Neoplasms, Uterine Neoplasms

NCT00109096 2007-05-17

Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy

Phase 2 Completed

Ovarian Neoplasms

NCT00055432 2006-09-15

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

Phase 2 Terminated

Ovarian Neoplasms